Metropolis Healthcare Limited

NSE METROPOLIS.NS

Metropolis Healthcare Limited Shareholders' Equity for the year ending March 31, 2024: USD 131.42 M

Metropolis Healthcare Limited Shareholders' Equity is USD 131.42 M for the year ending March 31, 2024, a 9.30% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Metropolis Healthcare Limited Shareholders' Equity for the year ending March 31, 2023 was USD 120.24 M, a 3.02% change year over year.
Metropolis Healthcare Limited Shareholders' Equity for the year ending March 31, 2022 was USD 116.71 M, a 20.94% change year over year.
Metropolis Healthcare Limited Shareholders' Equity for the year ending March 31, 2021 was USD 96.50 M, a 38.91% change year over year.
Metropolis Healthcare Limited Shareholders' Equity for the year ending March 31, 2020 was USD 69.47 M, a 15.34% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

NSE: METROPOLIS.NS

Metropolis Healthcare Limited

CEO	Mr. Surendran Chemmenkotil
IPO Date	April 15, 2019
Location	India
Headquarters	250-D, Udyog Bhavan
Employees	4,313
Sector	Healthcare
Industries Biotechnology Clinical Trials Dental Care Drugstores & Retail Pharmacies Medical Instruments Personal Care Pharmaceuticals Telehealth

Description

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.

Key trends

Past 5 years